{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:28:20Z","timestamp":1791224900037,"version":"4.1.0"},"reference-count":123,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.jsat.2007.01.008","type":"journal-article","created":{"date-parts":[[2007,6,16]],"date-time":"2007-06-16T10:11:18Z","timestamp":1181988678000},"page":"61-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"title":["Substance abuse and schizophrenia: Pharmacotherapeutic intervention"],"prefix":"10.1016","volume":"34","author":[{"given":"Alan I.","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas L.","family":"Noordsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary F.","family":"Brunette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"O'Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2007.01.008_bib1","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1037\/0003-066X.46.10.1036","article-title":"Co-occurring disorders among mentally ill jail detainees. Implications for public policy","volume":"46","author":"Abram","year":"1991","journal-title":"American Psychologist"},{"key":"10.1016\/j.jsat.2007.01.008_bib2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1192\/S0007125000297791","article-title":"Effect of substance misuse in early psychosis","volume":"172","author":"Addington","year":"1998","journal-title":"British Journal of Psychiatry. Supplement"},{"key":"10.1016\/j.jsat.2007.01.008_bib3","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1176\/ajp.151.5.780b","article-title":"Decreased substance use in chronically psychotic patients treated with clozapine","volume":"151","author":"Albanese","year":"1994","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib4","first-page":"300","article-title":"Diagnostic validation of conjoint schizophrenia and alcoholism","volume":"45","author":"Alterman","year":"1984","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib5","first-page":"83A","article-title":"Directly observed naltrexone treatment of alcohol dependence in schizophrenia: Preliminary analysis","volume":"26","author":"Batki","year":"2002","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.jsat.2007.01.008_bib6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1001\/archpsyc.63.4.426","article-title":"A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness","volume":"63","author":"Bellack","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.jcp.0000169419.38899.5b","article-title":"Aripiprazole in schizophrenia with cocaine dependence: A pilot study","volume":"25","author":"Beresford","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2007.01.008_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0272-7358(99)00033-1","article-title":"Substance use disorders in schizophrenia: Review, integration, and a proposed model","volume":"20","author":"Blanchard","year":"2000","journal-title":"Clinical Psychology Review"},{"key":"10.1016\/j.jsat.2007.01.008_bib9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/schbul\/16.1.81","article-title":"Psychotogenic drug use and neuroleptic response","volume":"16","author":"Bowers","year":"1990","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.jsat.2007.01.008_bib10","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1176\/ajp.147.9.1164","article-title":"Cocaine abuse among schizophrenic patients","volume":"147","author":"Brady","year":"1990","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib11","first-page":"118","article-title":"Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: A pilot study","volume":"56","author":"Brady","year":"1995","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4088\/JCP.v66n0613","article-title":"Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole","volume":"66","author":"Brown","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib13","article-title":"Quetiapine in psychiatric illness with comorbid stimulant abuse","author":"Brown","year":"2001"},{"key":"10.1016\/j.jsat.2007.01.008_bib14","series-title":"Toolkit for integrated dual disorders treatment","author":"Brunette","year":"2002"},{"key":"10.1016\/j.jsat.2007.01.008_bib15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/schbul\/sbl003","article-title":"Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders","volume":"32","author":"Brunette","year":"2006","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.jsat.2007.01.008_bib16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/09595230412331324590","article-title":"A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders","volume":"23","author":"Brunette","year":"2004","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.jsat.2007.01.008_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00005053-199701000-00003","article-title":"Relationships between symptoms of schizophrenia and substance abuse","volume":"185","author":"Brunette","year":"1997","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"Suppl. 3","key":"10.1016\/j.jsat.2007.01.008_bib18","first-page":"26","article-title":"Substance abuse in schizophrenia: A review","volume":"59","author":"Buckley","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib19","first-page":"272","article-title":"Clozapine treatment of comorbid substance abuse in patients with schizophrenia","volume":"36","author":"Buckley","year":"1999","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jsat.2007.01.008_bib20","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.biopsych.2005.01.026","article-title":"Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene \u00d7 environment interaction","volume":"57","author":"Caspi","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1017\/S0033291700027835","article-title":"Correlates of codisorders in homeless and never homeless indigent schizophrenic men","volume":"24","author":"Caton","year":"1994","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.jsat.2007.01.008_bib22","first-page":"1121","article-title":"Cigarette smoking among adults\u2014United States, 2004","volume":"54","author":"Centers for Disease Control and Prevention","year":"2005","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.jsat.2007.01.008_bib23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0006-3223(01)01134-9","article-title":"A neurobiological basis for substance abuse comorbidity in schizophrenia","volume":"50","author":"Chambers","year":"2001","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(00)00175-4","article-title":"Clozapine: Its impact on aggressive behavior among patients in a state psychiatric hospital","volume":"53","author":"Chengappa","year":"2002","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jsat.2007.01.008_bib25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0920-9964(98)00062-0","article-title":"Olanzapine response in treatment-refractory schizophrenic patients with a history of substance abuse","volume":"33","author":"Conley","year":"1998","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jsat.2007.01.008_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0920-9964(02)00379-1","article-title":"The effects of atypical antipsychotic medications on psychosocial outcomes","volume":"63","author":"Corrigan","year":"2003","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jsat.2007.01.008_bib27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0272-7358(97)00018-4","article-title":"HIV seroprevalence among people with severe mental illness in the United States: A critical review","volume":"17","author":"Cournos","year":"1997","journal-title":"Clinical Psychology Review"},{"key":"10.1016\/j.jsat.2007.01.008_bib28","article-title":"Effectiveness of quetiapine in patients with dual diagnosis","author":"Cruz","year":"2001"},{"key":"10.1016\/j.jsat.2007.01.008_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0376-8716(03)00064-4","article-title":"Testing hypotheses about the relationship between cannabis use and psychosis","volume":"71","author":"Degenhardt","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2007.01.008_bib30","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1176\/ajp.148.2.224","article-title":"Drug abuse in schizophrenic patients: Clinical correlates and reasons for use","volume":"148","author":"Dixon","year":"1991","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib31","first-page":"285","article-title":"Complications of severe mental illness related to alcohol and other drug use disorders","volume":"Vol. 14","author":"Drake","year":"1998"},{"key":"10.1016\/j.jsat.2007.01.008_bib32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1176\/appi.ps.52.4.469","article-title":"Implementing dual diagnosis services for clients with severe mental illness","volume":"52","author":"Drake","year":"2001","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.jsat.2007.01.008_bib33","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2975\/27.2004.360.374","article-title":"A review of treatments for people with severe mental illnesses and co-occurring substance use disorders","volume":"27","author":"Drake","year":"2004","journal-title":"Psychiatric Rehabilitation Journal"},{"key":"10.1016\/j.jsat.2007.01.008_bib34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jsat.2007.01.011","article-title":"A systematic review of psychosocial interventions for people with co-occurring substance use and severe mental disorders","volume":"34","author":"Drake","year":"2008","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2007.01.008_bib35","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00005053-198907000-00004","article-title":"Alcohol use and abuse in schizophrenia. A prospective community study","volume":"177","author":"Drake","year":"1989","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jsat.2007.01.008_bib36","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/oxfordjournals.schbul.a033464","article-title":"The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia","volume":"26","author":"Drake","year":"2000","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.jsat.2007.01.008_bib37","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1901\/jaba.2005.100-03","article-title":"The impact of enhanced incentives on vocational rehabilitation outcomes for dually diagnosed veterans","volume":"38","author":"Drebing","year":"2005","journal-title":"Journal of Applied Behavior Analysis"},{"key":"10.1016\/j.jsat.2007.01.008_bib38","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.biopsych.2004.12.006","article-title":"Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction","volume":"57","author":"D'Souza","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.jcp.0000162802.54076.18","article-title":"A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia","volume":"25","author":"Evins","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2007.01.008_bib40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0376-8716(99)00114-3","article-title":"Significant interaction between clozapine and cocaine in cocaine addicts","volume":"59","author":"Farren","year":"2000","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2007.01.008_bib41","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.ps.43.020192.001511","article-title":"Schizophrenia: Diathesis-stress revisited","volume":"43","author":"Fowles","year":"1992","journal-title":"Annual Review of Psychology"},{"key":"10.1016\/j.jsat.2007.01.008_bib42","first-page":"344","article-title":"Effects of clozapine on smoking in chronic schizophrenic outpatients","volume":"56","author":"George","year":"1995","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0006-3223(02)01339-2","article-title":"A placebo controlled trial of bupropion for smoking cessation in schizophrenia","volume":"52","author":"George","year":"2002","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib44","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1176\/appi.ajp.157.11.1835","article-title":"Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia","volume":"157","author":"George","year":"2000","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib45","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.addbeh.2006.05.012","article-title":"Do individuals with a severe mental illness experience greater alcohol and drug-related problems? A test of the supersensitivity hypothesis","volume":"32","author":"Gonzalez","year":"2007","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.jsat.2007.01.008_bib46","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1023\/A:1013026318450","article-title":"Recent victimization in women and men with severe mental illness: Prevalence and correlates","volume":"14","author":"Goodman","year":"2001","journal-title":"Journal of Traumatic Stress"},{"key":"10.1016\/j.jsat.2007.01.008_bib47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0920-9964(02)00231-1","article-title":"Alcohol and cannabis use in schizophrenia: Effects of clozapine vs. risperidone","volume":"60","author":"Green","year":"2003","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jsat.2007.01.008_bib48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.psychres.2004.05.005","article-title":"Clozapine reduces alcohol drinking in Syrian golden hamsters","volume":"128","author":"Green","year":"2004","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.jsat.2007.01.008_bib49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/1568007024606230","article-title":"Treatment of schizophrenia and comorbid substance use disorder","volume":"1","author":"Green","year":"2002","journal-title":"Current Drug Targets. CNS and Neurological Disorders"},{"key":"10.1016\/j.jsat.2007.01.008_bib50","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/10673229909017206","article-title":"Clozapine for comorbid substance use disorder and schizophrenia: Do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?","volume":"6","author":"Green","year":"1999","journal-title":"Harvard Review of Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib51","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0920-9964(95)00108-5","article-title":"Relapse in schizophrenia: Is there a relationship to substance abuse?","volume":"20","author":"Gupta","year":"1996","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jsat.2007.01.008_bib52","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1176\/ps.50.1.62","article-title":"Criminal victimization of persons with severe mental illness","volume":"50","author":"Hiday","year":"1999","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.jsat.2007.01.008_bib53","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.phrs.2005.05.012","article-title":"Effect of topiramate augmentation on two patients suffering from schizophrenia or bipolar disorder with comorbid alcohol abuse","volume":"52","author":"Huguelet","year":"2005","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.jsat.2007.01.008_bib54","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1530-0277.1987.tb01312.x","article-title":"Liver toxicity encountered in the Veterans Administration trial of disulfiram in alcoholics","volume":"11","author":"Iber","year":"1987","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.jsat.2007.01.008_bib55","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","article-title":"Oral topiramate for treatment of alcohol dependence: A randomised controlled trial","volume":"361","author":"Johnson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jsat.2007.01.008_bib56","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0269881105051542","article-title":"Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: A potent anti-craving effect?","volume":"19","author":"Kalyoncu","year":"2005","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.jsat.2007.01.008_bib57","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4088\/JCP.v63n0903","article-title":"Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder","volume":"63","author":"Kane","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib58","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1176\/ajp.142.11.1259","article-title":"The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence","volume":"142","author":"Khantzian","year":"1985","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib59","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/10673229709030550","article-title":"The self-medication hypothesis of substance use disorders: A reconsideration and recent applications","volume":"4","author":"Khantzian","year":"1997","journal-title":"Harvard Review of Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib60","first-page":"133","article-title":"Disulfiram in the treatment of alcoholic patients with schizophrenia","volume":"41","author":"Kingsbury","year":"1990","journal-title":"Hospital & Community Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0920-9964(95)00102-6","article-title":"The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse","volume":"20","author":"Kirkpatrick","year":"1996","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jsat.2007.01.008_bib62","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1176\/ajp.143.7.867","article-title":"Outpatient treatment of patients with substance abuse and coexisting psychiatric disorders","volume":"143","author":"Kofoed","year":"1986","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib63","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/archpsyc.63.6.622","article-title":"Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder","volume":"63","author":"Krakowski","year":"2006","journal-title":"Archives of General Psychiatry"},{"issue":"Suppl.","key":"10.1016\/j.jsat.2007.01.008_bib64","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0920-9964(98)00162-5","article-title":"Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients","volume":"35","author":"Krystal","year":"1999","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jsat.2007.01.008_bib65","first-page":"855","article-title":"Clozapine and substance abuse in patients with schizophrenia","volume":"43","author":"Lee","year":"1998","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib66","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2007.01.008_bib67","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1176\/appi.ajp.160.8.1396","article-title":"Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: A randomized, double-blind trial of olanzapine versus haloperidol","volume":"160","author":"Lieberman","year":"2003","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib68","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archpsyc.1994.03950040017002","article-title":"Cannabis abuse and the course of recent-onset schizophrenic disorders","volume":"51","author":"Linszen","year":"1994","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib69","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0740-5472(01)00205-7","article-title":"Olanzapine treatment for patients with schizophrenia and substance abuse","volume":"21","author":"Littrell","year":"2001","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2007.01.008_bib70","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00005053-199402000-00008","article-title":"Relationship of positive and negative symptoms to cocaine abuse in schizophrenia","volume":"182","author":"Lysaker","year":"1994","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jsat.2007.01.008_bib71","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1176\/ajp.152.6.959a","article-title":"Reduction of comorbid substance abuse with clozapine","volume":"152","author":"Marcus","year":"1995","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib72","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF02246063","article-title":"Haloperidol increases smoking in patients with schizophrenia","volume":"119","author":"McEvoy","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jsat.2007.01.008_bib73","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0006-3223(98)00377-1","article-title":"Smoking and therapeutic response to clozapine in patients with schizophrenia","volume":"46","author":"McEvoy","year":"1999","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib74","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/ajp.2006.163.4.600","article-title":"Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment","volume":"163","author":"McEvoy","year":"2006","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib75","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11920-996-0047-6","article-title":"Suicidality in schizophrenia: A review of the evidence for risk factors and treatment options","volume":"4","author":"Meltzer","year":"2002","journal-title":"Current Psychiatry Reports"},{"key":"10.1016\/j.jsat.2007.01.008_bib76","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archpsyc.60.1.82","article-title":"Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT)","volume":"60","author":"Meltzer","year":"2003","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib77","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00004714-200102000-00022","article-title":"Heroin and schizophrenia: Subjective responses to abused drugs in dually diagnosed patients","volume":"21","author":"Miotto","year":"2001","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2007.01.008_bib78","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1176\/appi.ps.56.10.1254","article-title":"The effectiveness of skills training for improving outcomes in supported employment","volume":"56","author":"Mueser","year":"2005","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.jsat.2007.01.008_bib79","series-title":"Integrated treatment for dual disorders: A guide to effective practice","author":"Mueser","year":"2003"},{"key":"10.1016\/j.jsat.2007.01.008_bib80","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/schbul\/16.1.31","article-title":"Prevalence of substance abuse in schizophrenia: Demographic and clinical correlates","volume":"16","author":"Mueser","year":"1990","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.jsat.2007.01.008_bib81","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1176\/appi.ps.52.4.501","article-title":"Six-month outcomes for patients who switched to olanzapine treatment","volume":"52","author":"Noordsy","year":"2001","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.jsat.2007.01.008_bib82","article-title":"Switching to olanzapine in naturalistic community care","author":"Noordsy","year":"2001"},{"issue":"Suppl. 3","key":"10.1016\/j.jsat.2007.01.008_bib83","first-page":"22","article-title":"Recovery-oriented psychopharmacology: Redefining the goals of antipsychotic treatment","volume":"61","author":"Noordsy","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib84","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1176\/ps.47.8.853","article-title":"Medication noncompliance and substance abuse among patients with schizophrenia","volume":"47","author":"Owen","year":"1996","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.jsat.2007.01.008_bib85","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/10550490500419052","article-title":"Atypical antipsychotic medication and substance use-related outcomes in the treatment of schizophrenia","volume":"15","author":"Petrakis","year":"2006","journal-title":"American Journal on Addictions"},{"key":"10.1016\/j.jsat.2007.01.008_bib86","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/schbul\/sbl010","article-title":"Psychotic spectrum disorders and alcohol abuse: A review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram","volume":"32","author":"Petrakis","year":"2006","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.jsat.2007.01.008_bib87","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00213-003-1658-9","article-title":"Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia","volume":"172","author":"Petrakis","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jsat.2007.01.008_bib88","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/jnnp.2005.079228","article-title":"Increased extrapyramidal symptoms in patients with schizophrenia and a comorbid substance use disorder","volume":"77","author":"Potvin","year":"2006","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib89","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1185\/030079906X112561","article-title":"Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: An open-label trial","volume":"22","author":"Potvin","year":"2006","journal-title":"Current Medical Research and Opinion"},{"key":"10.1016\/j.jsat.2007.01.008_bib90","first-page":"121","article-title":"Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: Towards testable hypotheses","volume":"18","author":"Potvin","year":"2003","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2007.01.008_bib91","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1177\/070674370404901020","article-title":"The effect of quetiapine on cannabis use in 8 psychosis patients with drug dependency","volume":"49","author":"Potvin","year":"2004","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib92","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.","volume":"264","author":"Regier","year":"1990","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jsat.2007.01.008_bib93","first-page":"79","article-title":"Recent psychostimulant use in hospitalized schizophrenics","volume":"46","author":"Richard","year":"1985","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib94","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1176\/appi.ps.55.4.445","article-title":"Outcomes of managing disability benefits among patients with substance dependence and severe mental illness","volume":"55","author":"Ries","year":"2004","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.jsat.2007.01.008_bib95","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2105\/AJPH.91.1.31","article-title":"Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness","volume":"91","author":"Rosenberg","year":"2001","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2007.01.008_bib96","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/comp.2001.24576","article-title":"Determinants of risk behavior for human immunodeficiency virus\/acquired immunodeficiency syndrome in people with severe mental illness","volume":"42","author":"Rsenberg","year":"2001","journal-title":"Comprehensive Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib97","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11920-005-0082-8","article-title":"Treatment of substance use disorders in schizophrenia: A unifying neurobiological mechanism?","volume":"7","author":"Roth","year":"2005","journal-title":"Current Psychiatry Reports"},{"key":"10.1016\/j.jsat.2007.01.008_bib98","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1177\/070674370605100808","article-title":"Long-acting injectable risperidone compared with zuclopenthixol in the treatment of schizophrenia with substance abuse comorbidity","volume":"51","author":"Rubio","year":"2006","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib99","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archpsyc.62.1.37","article-title":"Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: A double-blind placebo-controlled study","volume":"62","author":"Salloum","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0920-9964(00)00063-3","article-title":"Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia","volume":"48","author":"Salyers","year":"2001","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jsat.2007.01.008_bib101","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/01.nmd.0000165089.14736.bf","article-title":"Cocaine abuse in schizophrenic patients treated with olanzapine versus haloperidol","volume":"193","author":"Sayers","year":"2005","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jsat.2007.01.008_bib102","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/oxfordjournals.schbul.a006933","article-title":"Increased early life stress and depressive symptoms in patients with comorbid substance abuse and schizophrenia","volume":"28","author":"Scheller-Gilkey","year":"2002","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.jsat.2007.01.008_bib103","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/schbul\/16.1.111","article-title":"Pharmacological treatment of substance-abusing schizophrenic patients","volume":"16","author":"Siris","year":"1990","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.jsat.2007.01.008_bib104","first-page":"127","article-title":"Adjunctive imipramine in substance-abusing dysphoric schizophrenic patients","volume":"29","author":"Siris","year":"1993","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1016\/j.jsat.2007.01.008_bib105","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1177\/070674370204700710","article-title":"Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence","volume":"47","author":"Smelson","year":"2002","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib106","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/01.jcp.0000194624.07611.5e","article-title":"The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: A preliminary report","volume":"26","author":"Smelson","year":"2006","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2007.01.008_bib107","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1192\/bjp.176.4.345","article-title":"Substance misuse, psychiatric disorder and violent and disturbed behaviour","volume":"176","author":"Soyka","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib108","series-title":"Textbook of schizophrenia","first-page":"303","article-title":"Pharmacotherapies","author":"Stroup","year":"2006"},{"issue":"1 Suppl. 1","key":"10.1016\/j.jsat.2007.01.008_bib109","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1097\/00004714-199502001-00003","article-title":"Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: Role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected]","volume":"15","author":"Svensson","year":"1995","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2007.01.008_bib110","first-page":"761","article-title":"Violence and psychiatric disorder in the community: Evidence from the Epidemiologic Catchment Area surveys","volume":"41","author":"Swanson","year":"1990","journal-title":"Hospital & Community Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib111","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archpsyc.63.5.490","article-title":"A national study of violent behavior in persons with schizophrenia","volume":"63","author":"Swanson","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib112","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.nmd.0000202575.79453.6e","article-title":"Substance use in persons with schizophrenia: Baseline prevalence and correlates from the NIMH CATIE study","volume":"194","author":"Swartz","year":"2006","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jsat.2007.01.008_bib113","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1176\/ajp.135.10.1213","article-title":"Marijuana use in schizophrenia: A clear hazard","volume":"135","author":"Treffert","year":"1978","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib114","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/archpsyc.1982.04290020013003","article-title":"Subtypes of drug abuse with psychosis. Demographic characteristics, clinical features, and family history","volume":"39","author":"Tsuang","year":"1982","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib115","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00004714-199308000-00012","article-title":"Clozapine effects on hostility and aggression in schizophrenia","volume":"13","author":"Volavka","year":"1993","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2007.01.008_bib116","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1037\/0033-295X.104.4.667","article-title":"Schizophrenia: A neural diathesis-stress model","volume":"104","author":"Walker","year":"1997","journal-title":"Psychological Review"},{"key":"10.1016\/j.jsat.2007.01.008_bib117","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/070674370505000415","article-title":"Aripiprazole reduces alcohol use","volume":"50","author":"Warsi","year":"2005","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib118","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1176\/ajp.2007.164.1.100","article-title":"A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence","volume":"164","author":"Weiss","year":"2007","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2007.01.008_bib119","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0140-6736(88)91815-6","article-title":"Drug abuse and mental illness","volume":"1","author":"Weller","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jsat.2007.01.008_bib120","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00005053-199410000-00017","article-title":"Clozapine reverses cocaine craving in a treatment-resistant mentally ill chemical abuser: A case report and a hypothesis","volume":"182","author":"Yovell","year":"1994","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jsat.2007.01.008_bib121","first-page":"309","article-title":"Adjunctive desipramine in the treatment of cocaine abusing schizophrenics","volume":"28","author":"Ziedonis","year":"1992","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1016\/j.jsat.2007.01.008_bib122","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00131746-200509000-00005","article-title":"Improving the care of individuals with schizophrenia and substance use disorders: Consensus recommendations","volume":"11","author":"Ziedonis","year":"2005","journal-title":"Journal of Psychiatric Practice"},{"key":"10.1016\/j.jsat.2007.01.008_bib123","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00004714-200002000-00016","article-title":"Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: A retrospective survey","volume":"20","author":"Zimmet","year":"2000","journal-title":"Journal of Clinical Psychopharmacology"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547207000931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547207000931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:31:17Z","timestamp":1760038277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547207000931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0740547207000931"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2007.01.008","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substance abuse and schizophrenia: Pharmacotherapeutic intervention","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2007.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}